Literature DB >> 11938817

[Ethological examination of Alzheimer's disease model rats treated with bushen yizhi decoction].

H Wang1, S Lai, J Sun.   

Abstract

OBJECTIVE: To explore the ethological improving effect of Bushen Yizhi Decoction (BSYZD) in treating model rat of Alzheimer's disease (AD).
METHODS: Ethologic examination was carried out with Morris water maze on young, aged, AD model, Huperzine A treated and BSYZD treated groups of rats.
RESULTS: In the BSYZD treated group, the escape latency (EL) curve placed between that of the young, aged and AD model, Huperzine A treated group; the percentage of middle circle swim path, the 40 cm circle swimming time, and the platform-crossing times were not different from those in the normal aged group, but were different significantly as compared with the AD model group, P < 0.05.
CONCLUSION: BSYZD could ameliorate the behavior deficits of AD model.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11938817

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  3 in total

1.  Alleviating effects of Bushen-Yizhi formula on ibotenic acid-induced cholinergic impairments in rat.

Authors:  Xue-Qin Hou; Lei Zhang; Cong Yang; Cui-Ping Rong; Wen-Qing He; Chun-Xia Zhang; Shi Li; Ru-Yu Su; Xiang Chang; Ji-Huan Qin; Yun-Bo Chen; Shao-Xiang Xian; Qi Wang
Journal:  Rejuvenation Res       Date:  2015-04       Impact factor: 4.663

2.  Aβ damages learning and memory in Alzheimer's disease rats with kidney-yang deficiency.

Authors:  Dongmei Qi; Yongfa Qiao; Xin Zhang; Huijuan Yu; Bin Cheng; Haifa Qiao
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-08       Impact factor: 2.629

3.  Ethyl Acetate Extract Components of Bushen-Yizhi Formula Provides Neuroprotection against Scopolamine-induced Cognitive Impairment.

Authors:  Shi-Jie Zhang; Dan Luo; Lin Li; Rui-Rong Tan; Qing-Qing Xu; Jie Qin; Lei Zhu; Na-Chuan Luo; Ting-Ting Xu; Rong Zhang; Lei Yang; Qi Wang
Journal:  Sci Rep       Date:  2017-08-29       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.